2002
DOI: 10.1002/bit.10549
|View full text |Cite
|
Sign up to set email alerts
|

Novel CNBP‐ and La‐based translation control systems for mammalian cells

Abstract: Throughout the development of Xenopus, production of ribosomal proteins (rp) is regulated at the translational level. Translation control is mediated by a terminal oligopyrimidine element (TOP) present in the 5Ј untranslated region (UTR) of rp-encoding mRNAs. TOP elements adopt a specific secondary structure that prevents ribosome-binding and translation-initiation of rpencoding mRNAs. However, binding of CNBP (cellular nucleic acid binding protein) or La proteins to the TOP hairpin structure abolishes the TOP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0

Year Published

2003
2003
2008
2008

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 70 publications
0
24
0
Order By: Relevance
“…Different metabolic engineering strategies have been designed since to reduce production bottlenecks and improve the specific productivity of mammalian host cell lines or the quality of the product. Most successful examples include (i) transcription engineering using trigger-inducible expression systems (Schlatter and Fussenegger, 2003), (ii) translation engineering consisting of improving ribosomal entry and translationinitiation (Underhill et al, 2003;Umaña et al, 1999), (iii) glycoengineering improving the ADCC activity of therapeutic antibodies (Prati et al, 2002), (iv) controlled proliferation technology which redirects metabolic energy from cell growth to product formation (Fussenegger et al, 1998) and (v) anti-apoptosis engineering which is based on ectopic expression of survival genes (Ishaque and Al-Rubeai, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Different metabolic engineering strategies have been designed since to reduce production bottlenecks and improve the specific productivity of mammalian host cell lines or the quality of the product. Most successful examples include (i) transcription engineering using trigger-inducible expression systems (Schlatter and Fussenegger, 2003), (ii) translation engineering consisting of improving ribosomal entry and translationinitiation (Underhill et al, 2003;Umaña et al, 1999), (iii) glycoengineering improving the ADCC activity of therapeutic antibodies (Prati et al, 2002), (iv) controlled proliferation technology which redirects metabolic energy from cell growth to product formation (Fussenegger et al, 1998) and (v) anti-apoptosis engineering which is based on ectopic expression of survival genes (Ishaque and Al-Rubeai, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…RpS6 is a component of the 40S subunit and is the major phosphoprotein of the ribosome, containing five serine residues that are phosphorylated. Ribosomes with the highest degree of RpS6 phosphorylation have an advantage in mobilizing into polysomes, although RpS6 phosphorylation alone may not be sufficient for polysome formation (21,32,53). Phosphorylation of RpS6 tightly correlates with an increase in translation in the cell, particularly of TOP messages (which contain a 5Ј-terminal oligopyrimidine tract).…”
Section: Discussionmentioning
confidence: 99%
“…pCS35 and pCS37: In order to enable immunodetection of eIF4G ⌬I -ЈFKBP 3 (pCS8) and eIF4G ⌬II -ЈFKBP 3 (pCS23) they were fused by PCR to a Hemagglutinin A epitope tag (YPYDVPDYA) using oligonucleotides OCS16 (gatcATTAACGCCGGCGCtATTCCA; notI site in bold, beginning of Kozak sequence underlined, annealing sequence in capital letters) or OCS20 (gatcgcggccgCCACCATGAA-CACGCCTTCT; NotI site in bold, Kozak sequence underlined, annealing sequence in capital letters) and OCS17 pSS106, pSS113, and pSS123: Construction of the prokaryotic cloning vectors pSS106, encoding the puromycin resistance conferring gene (pur), pSS113 harboring the SEAP gene as well as the eukaryotic expression vector pSS123 containing the low molecular weight urokinasetype plasminogen activator (u-PA LMW ) have been described before (Schlatter et al, 2002;Schlatter and Fussenegger, 2003).…”
Section: Construction Of Precursor Vectors (Seementioning
confidence: 99%